EYEN Eyenovia Inc.

Eyenovia Inc is a clinical stage biopharmaceutical company. It is engaged in developing a pipeline of ophthalmology products utilizing patented piezo-print technology to deliver micro-therapeutics topically to the eye.

$1.84  +0.02 (1.10%)
As of 06/27/2022 16:00:01 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  01/25/2018
Outstanding shares:  33,568,554
Average volume:  142,499
Market cap:   $61,094,768
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      
Valuation   (See tab for details)
PE ratio:   -32.88
PB ratio:   1.94
PS ratio:   5.09
Return on equity:   -49.56%
Net income %:   -123.05%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy